BH

Bradley Hyman

Scientific Advisor at Arvinas

Dr. Bradley Hyman is the John B. Penney, Jr. Professor of Neurology at Harvard Medical School and Massachusetts General Hospital. He directs the Alzheimer's disease research unit at MassGeneral Institute for Neurodegenerative Diseases (MIND), with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. Dr. Hyman's laboratory studies the anatomical and molecular basis of dementia in Alzheimer's disease and dementia with Lewy bodies, with the goal to understand the underlying biology of dementias, how genetic risk factors impact the disease, and how to develop new therapies that may help patients. Dr. Hyman earned his undergraduate degree from Northwestern University and received his M.D. and Ph.D. from the University of Iowa. He has been a recipient of the Metropolitan Life Award, the Potamkin Prize, a National Institute on Aging Merit award, and an Alzheimer Association Pioneer Award. He is the current Director of the Massachusetts Alzheimer's Disease Research Center.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Arvinas

5 followers

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.


Industries

Employees

201-500

Links